Corrigendum to "Comparison of [17(20)E]-21-Norpregnene oxazolinyl and benzoxazolyl derivatives as inhibitors of CYP17A1 activity and prostate carcinoma cells growth" [Steroids 129 (2018) 24-34]

Steroids. 2018 Aug:136:93. doi: 10.1016/j.steroids.2018.06.001.
No abstract available

Publication types

  • Published Erratum